Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Ethics Med Public Health ; 22: 100717, 2022 Jun.
Article in English | MEDLINE | ID: mdl-34485658

ABSTRACT

Introduction: Coronavirus disease (COVID-19) is a newly emerging infectious disease that bringing a heavy workload on nursing staff. Objective: This study explores the nurses' experiences of providing ethical care for patients with COVID-19. Methods: This qualitative study was carried out based on hermeneutic phenomenology. Unstructured interviews were conducted with 18 Iranian nurses. Data were analyzed based on the hermeneutic approach using the Diekelmann approach. Results: Three themes emerged: strong clinical dilemma, flourishing of professional values, and strengthening human and organizational communication. Conclusion: The findings highlight ethical care and its dimensions for COVID-19 patients. Nurses need support from health managers to provide ethical care in such health crises.

2.
Hum Exp Toxicol ; 39(5): 653-661, 2020 May.
Article in English | MEDLINE | ID: mdl-31876186

ABSTRACT

BACKGROUND: Cadmium is an environmental pollutant which can induce the overproduction of free radicals while suppressing the antioxidant defense system. Curcumin is considered a free-radical scavenger and a potent antioxidant. This study was conducted to investigate the effect of curcumin on serum antioxidant enzymes and histopathological changes in mice treated with cadmium. METHODS: In this experimental study, adult mice were divided into four groups, namely, control, cadmium chloride (5 mg kg-1), curcumin (100 mg kg-1), and curcumin+cadmium chloride. The animals received curcumin 24 h prior to cadmium chloride injection. After 24 h, blood samples were collected and used to assess the levels of malondialdehyde (MDA), antioxidant enzymes activity (catalase, superoxide dismutase, and glutathione peroxidase), total glutathione, total thiol, and hydrogen peroxide. Histopathological evaluation was also performed for testicular tissue. RESULTS: Mice treated with cadmium showed a significant (p < 0.001) decrease in the activity of antioxidant enzymes, serum amounts of total glutathione and total thiol, and the diameter of seminiferous tubules compared to the control group. This pollutant also significantly (p < 0.001) increased serum levels of MDA and hydrogen peroxide and the lumen diameter of seminiferous tubules compared to the control group. In the curcumin+cadmium group, curcumin significantly (p < 0.001) reversed the adverse effects of cadmium, compared to the cadmium group. In addition, curcumin alone significantly (p < 0.001) increased serum glutathione peroxidase activity and thiol content compared to the control group. CONCLUSION: Curcumin, as a potent antioxidant, could compensate the adverse effects of cadmium on lipid and protein peroxidation, potentiated serum antioxidant defense system, and ameliorated some morphometrical parameters in the testis of cadmium-treated mice.


Subject(s)
Cadmium Chloride/toxicity , Curcumin/pharmacology , Oxidative Stress/drug effects , Protective Agents/pharmacology , Testis/drug effects , Animals , Catalase/metabolism , Glutathione/blood , Glutathione Peroxidase/metabolism , Hydrogen Peroxide/blood , Male , Malondialdehyde/blood , Mice , Superoxide Dismutase/metabolism , Testis/pathology
3.
Allergol. immunopatol ; 47(3): 234-240, mayo-jun. 2019. graf, tab
Article in English | IBECS | ID: ibc-186483

ABSTRACT

Introduction and objectives: Allergic rhinitis (AR) is a classic Th2-mediated disease, with important contributions to the pathology of interleukins 4, 5, and 13. The co-stimulatory molecule of OX40 and its ligand interaction participate in the immune response by regulation of Th1/Th2 cells balance. Considering the paucity of information on the relation between OX40 ligand (OX40L) and AR, this study aimed to examine its expression on B lymphocytes. Patients and methods: This case-control study consisted of 20 AR patients and 20 healthy subjects. The serum level of total immunoglobulin E (IgE) was measured using the electro-chemiluminescence (ECL) technology. The percentage of B-lymphocytes expressing OX40L was assessed by flow cytometry. The amounts of IL-4 in CD4+ T cells culture supernatant was also measured by the enzyme-linked immunosorbent assay (ELISA). Results: OX40L expression on B lymphocytes of patients was significantly higher than the control group (44.32 ± 19.21% vs. 2.79 ± 2.48% respectively, p < 0.001). In AR patients, OX40L expression correlated positively with the levels of serum total IgE and IL-4 produced by CD4+ T lymphocytes (p < 0.01 - p < 0.05) respectively. Conclusions: Collectively, the findings of this work suggest that there is a relationship between the OX40L expression level on B lymphocytes and allergic markers such as IgE and IL-4 in patients with allergic rhinitis


No disponible


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , B-Lymphocytes/immunology , Biomarkers/blood , Immunoglobulin E/blood , Interleukin-4/blood , OX40 Ligand/metabolism , Rhinitis, Allergic/immunology , Th2 Cells/immunology , CD4 Antigens/metabolism , Case-Control Studies , Up-Regulation , Cells, Cultured
4.
Allergol Immunopathol (Madr) ; 47(3): 234-240, 2019.
Article in English | MEDLINE | ID: mdl-30454861

ABSTRACT

INTRODUCTION AND OBJECTIVES: Allergic rhinitis (AR) is a classic Th2-mediated disease, with important contributions to the pathology of interleukins 4, 5, and 13. The co-stimulatory molecule of OX40 and its ligand interaction participate in the immune response by regulation of Th1/Th2 cells balance. Considering the paucity of information on the relation between OX40 ligand (OX40L) and AR, this study aimed to examine its expression on B lymphocytes. PATIENTS AND METHODS: This case-control study consisted of 20 AR patients and 20 healthy subjects. The serum level of total immunoglobulin E (IgE) was measured using the electro-chemiluminescence (ECL) technology. The percentage of B-lymphocytes expressing OX40L was assessed by flow cytometry. The amounts of IL-4 in CD4+ T cells culture supernatant was also measured by the enzyme-linked immunosorbent assay (ELISA). RESULTS: OX40L expression on B lymphocytes of patients was significantly higher than the control group (44.32±19.21% vs. 2.79±2.48% respectively, p<0.001). In AR patients, OX40L expression correlated positively with the levels of serum total IgE and IL-4 produced by CD4+ T lymphocytes (p<0.01 - p<0.05) respectively. CONCLUSIONS: Collectively, the findings of this work suggest that there is a relationship between the OX40L expression level on B lymphocytes and allergic markers such as IgE and IL-4 in patients with allergic rhinitis.


Subject(s)
B-Lymphocytes/immunology , Biomarkers/blood , Immunoglobulin E/blood , Interleukin-4/blood , OX40 Ligand/metabolism , Rhinitis, Allergic/immunology , Th2 Cells/immunology , Adolescent , Adult , CD4 Antigens/metabolism , Case-Control Studies , Cells, Cultured , Female , Humans , Male , Middle Aged , Up-Regulation , Young Adult
5.
Andrologia ; 50(2)2018 Mar.
Article in English | MEDLINE | ID: mdl-28660655

ABSTRACT

Globozoospermia is a severe sperm morphological anomaly leading to primary infertility and low fertilisation following intracytoplasmic sperm injection (ICSI). This phenotype is observed in less than 0.1% of infertile men and is determined by small, round-headed spermatozoa with absence of an acrosomal cap, acrosome protease and also cytoskeletal proteins. Failure of oocyte activation is considered as the main cause of fertilisation failure in these individuals post-ICSI. Therefore, artificial oocyte activation (AOA) along with ICSI is commonly implemented. However, based on previous report, fertilisation rate remains low despite implementation of ICSI-AOA. Therefore, other mechanisms like sperm chromatin packaging and DNA fragmentation may account for low fertilisation and development post-ICSI-AOA. Therefore, this study aims to assess and compare the degree of sperm protamine deficiency and DNA fragmentation in large population of infertile men with total globozoospermia (30 globozoospermic men presenting with 100% round-headed spermatozoa) with 22 fertile individuals using chromomycin A3 and TUNEL assay respectively. Results clearly show that mean of sperm concentration and percentage of sperm motility were significantly lower, while percentage of sperm abnormal morphology, protamine-deficient and DNA-fragmented spermatozoa were significantly higher in infertile men with globozoospermia compared to fertile men. Therefore, increased sperm DNA damage in globozoospermia is likely related to defective DNA compaction and antioxidant therapy before ICSI-AOA could be recommended as an appropriate option before ICSI-AOA.


Subject(s)
Acrosome/pathology , Chromatin/genetics , DNA Fragmentation , Protamines/metabolism , Teratozoospermia/genetics , Adult , Antioxidants/therapeutic use , Humans , In Situ Nick-End Labeling , Male , Protamines/genetics , Sperm Injections, Intracytoplasmic/adverse effects , Sperm Injections, Intracytoplasmic/methods , Sperm Motility , Teratozoospermia/drug therapy
6.
Allergol. immunopatol ; 45(2): 183-192, mar.-abr. 2017. tab, graf
Article in English | IBECS | ID: ibc-160524

ABSTRACT

BACKGROUND: Common variable immunodeficiency (CVID) is a heterogeneous disease, characterised by hypogammaglobulinaemia leading to recurrent infections and various complications. The aim of this study was to classify CVID patients based on four known classifications (Paris, Freiburg, EUROclass, and B-cell patterns) by measurement of B-cell subsets and to assess the relation of each classification with clinical manifestations. METHODS: We measured all B-cell subsets as both absolute count and percentage in 30 CVID patients and 30 healthy individuals using four-colour flow cytometry. Moreover, we evaluated antibody responses to pneumococcal vaccine in patients. RESULTS: A significant reduction in percentage of terminal B-cell subsets (total, marginal zone-like, switched memory, IgM-only memory, total memory B-cells and plasmablast) and absolute count of all B-cell subsets along with a strong increase in CD21low B-cells has been observed in patients. Patients with splenomegaly and hepatomegaly clustered in group Ia, smB+21low and group 1 based on known classifications, and significantly tended to have a decreased transitional and marginal zone-like B-cells count, as well as an increase in CD21low B-cell counts. Patients with lymphadenopathy, bronchiectasis and allergy had a significant decrease in absolute count of total memory, switched memory and total B-cells, respectively. CONCLUSION: Classification of patients could provide useful information to guide clinicians in long-term follow-up of CVID patients. Our data demonstrate that it may be more accurate to use absolute counts of B-cell subpopulations in CVID patients because absolute counts of B-cell subsets are more associated with clinical manifestations compared with their percentage and also four known classifications


No disponible


Subject(s)
Humans , Male , Female , Common Variable Immunodeficiency/complications , Common Variable Immunodeficiency/immunology , Common Variable Immunodeficiency/pathology , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/pathology , Common Variable Immunodeficiency , Immunoglobulin M/immunology , Flow Cytometry/methods , Flow Cytometry , Enzyme-Linked Immunosorbent Assay/methods , Vaccination/methods
7.
Inflammation ; 40(1): 259-274, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27896542

ABSTRACT

The Th1- and Treg cell-related immune responses play key roles in the modulation of Th2 cell-related allergic disorders. The aim was to evaluate the effects of CPG, MPLA, and BCG on the number of Th1-, Th2-, and Treg cell-related parameters in an animal model of asthma. BALB/c mice were divided into five groups and immunized subcutaneously (SC) on days 1, 15, and 22 with allergen Derp2. Three groups of mice were pretreated SC on days 0, 14, and 21 with CPG, CPG + MPLA, or CPG + BCG. All mice were then challenged intranasally with Derp2 on days 28-37. Blood samples were collected from the retro-orbital sinus, on days 0, 23, and 40. The serum levels of IL-4, IFN-γ, IgE, and IgG2a were measured using ELISA technique. The blood number of Th1 and Treg cells was determined using flow cytometry. At the sensitization phase, the number of Th1 and the serum levels of IFN-γ and IgG2a were significantly increased in the Derp2-sensitized group pretreated with CPG plus MPLA, and the number of Treg cells was significantly elevated in Derp2-sensitized mice pretreated with CPG or CPG plus MPLA as compared with that in Derp2-sensitized control mice. At the challenge phase, the number of Th1 was significantly elevated in Derp2-sensitized mice pretreated with CPG plus MPLA, CPG plus BCG, or CPG; the count of Treg cells was significantly increased in Derp2-sensitized mice pretreated with CPG plus BCG group; and the levels of IFN-γ and IgG2a were significantly enhanced in the Derp2-sensitized group pretreated with CPG plus MPLA in comparison with those in Derp2-sensitized control mice. The scores of inflammation and mucus secretion in the lung were significantly decreased in the Derp2-sensitized group pretreated with CPG, BCG, and CPG plus MPLA in comparison with those in the Derp2-sensitized control group. These results showed that BCG, MPLA, and CPG modulate Th1-, Th2-, and Treg-related parameters and ameliorate lung inflammatory parameters in a mouse model of asthma.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Asthma/drug therapy , Immunomodulation/drug effects , Acute Disease , Adjuvants, Immunologic/administration & dosage , Animals , Antigens, Dermatophagoides , Asthma/immunology , Inflammation/therapy , Lipid A/analogs & derivatives , Mice , Mice, Inbred BALB C , Mycobacterium bovis , Oligodeoxyribonucleotides , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Th2 Cells/immunology
8.
Allergol Immunopathol (Madr) ; 45(2): 183-192, 2017.
Article in English | MEDLINE | ID: mdl-27717724

ABSTRACT

BACKGROUND: Common variable immunodeficiency (CVID) is a heterogeneous disease, characterised by hypogammaglobulinaemia leading to recurrent infections and various complications. The aim of this study was to classify CVID patients based on four known classifications (Paris, Freiburg, EUROclass, and B-cell patterns) by measurement of B-cell subsets and to assess the relation of each classification with clinical manifestations. METHODS: We measured all B-cell subsets as both absolute count and percentage in 30 CVID patients and 30 healthy individuals using four-colour flow cytometry. Moreover, we evaluated antibody responses to pneumococcal vaccine in patients. RESULTS: A significant reduction in percentage of terminal B-cell subsets (total, marginal zone-like, switched memory, IgM-only memory, total memory B-cells and plasmablast) and absolute count of all B-cell subsets along with a strong increase in CD21low B-cells has been observed in patients. Patients with splenomegaly and hepatomegaly clustered in group Ia, smB+21low and group 1 based on known classifications, and significantly tended to have a decreased transitional and marginal zone-like B-cells count, as well as an increase in CD21low B-cell counts. Patients with lymphadenopathy, bronchiectasis and allergy had a significant decrease in absolute count of total memory, switched memory and total B-cells, respectively. CONCLUSION: Classification of patients could provide useful information to guide clinicians in long-term follow-up of CVID patients. Our data demonstrate that it may be more accurate to use absolute counts of B-cell subpopulations in CVID patients because absolute counts of B-cell subsets are more associated with clinical manifestations compared with their percentage and also four known classifications.


Subject(s)
B-Lymphocyte Subsets/immunology , Common Variable Immunodeficiency/immunology , Adolescent , Adult , Bronchiectasis , Child , Common Variable Immunodeficiency/classification , Common Variable Immunodeficiency/physiopathology , Female , Hepatomegaly , Humans , Immunologic Memory , Immunophenotyping , Lymphadenopathy , Lymphocyte Count , Male , Middle Aged , Receptors, Complement 3d/metabolism , Splenomegaly , Young Adult
9.
Allergol. immunopatol ; 43(1): 37-41, ene.-feb. 2015. tab, graf
Article in English | IBECS | ID: ibc-133253

ABSTRACT

BACKGROUND: Mast cell and basophiles are thought to be central to inflammation that has an allergic basis as allergens activate these cells in an IgE-dependent manner to generate mediators such as histamine, eicosanoids and cytokines. Phosphodiesterase (PDE) is known to exist as multiple molecular forms of enzyme that metabolise the second messengers. Studies of our own have shown that, of a variety of isoform-selective drugs, the PDE4-selective inhibitors, such as rolipram, attenuate the IgE-mediated release of histamine from human basophiles but not from human lung mast cells (HLMC). The main aim of the present study was to characterise the type and role of PDEs regulating human skin mast cells by using selective and non-selective PDE inhibitors. METHODS: Cells were pre-treated for 15 min with these agents and then challenged with an optimal releasing concentration of anti IgE (1:300) for a further 25 min for the release of histamine. RESULTS: The data show that all the selective PDE-inhibitor compounds (10−5 M) were ineffective whereas the non-selective PDE inhibitor, theophylline (10−3 M), inhibited histamine release from HSMC (74 ± 4% inhibition; p < 0.05). None of the selective PDE inhibitors had any effect on histamine release from HLMC whereas, in basophiles, compounds with activity at PDE 4 (rolipram, denbufylline, Ro-2017, Org 30029) were effective inhibitors of histamine release. CONCLUSION: The data suggest that unlike most inflammatory cells, PDE-selective inhibitors are ineffective stabilisers of HSMC activity which is similar to HLMC


No disponible


Subject(s)
Humans , Mast Cells/immunology , Histamine Release , Phosphodiesterase Inhibitors/pharmacokinetics , Basophils , Hypersensitivity, Immediate/drug therapy , Cyclic GMP-Dependent Protein Kinases/pharmacokinetics
10.
Allergol Immunopathol (Madr) ; 43(1): 37-41, 2015.
Article in English | MEDLINE | ID: mdl-24231152

ABSTRACT

BACKGROUND: Mast cell and basophiles are thought to be central to inflammation that has an allergic basis as allergens activate these cells in an IgE-dependent manner to generate mediators such as histamine, eicosanoids and cytokines. Phosphodiesterase (PDE) is known to exist as multiple molecular forms of enzyme that metabolise the second messengers. Studies of our own have shown that, of a variety of isoform-selective drugs, the PDE4-selective inhibitors, such as rolipram, attenuate the IgE-mediated release of histamine from human basophiles but not from human lung mast cells (HLMC). The main aim of the present study was to characterise the type and role of PDEs regulating human skin mast cells by using selective and non-selective PDE inhibitors. METHODS: Cells were pre-treated for 15 min with these agents and then challenged with an optimal releasing concentration of anti IgE (1:300) for a further 25 min for the release of histamine. RESULTS: The data show that all the selective PDE-inhibitor compounds (10(-5)M) were ineffective whereas the non-selective PDE inhibitor, theophylline (10(-3)M), inhibited histamine release from HSMC (74 ± 4% inhibition; p<0.05). None of the selective PDE inhibitors had any effect on histamine release from HLMC whereas, in basophiles, compounds with activity at PDE 4 (rolipram, denbufylline, Ro-2017, Org 30029) were effective inhibitors of histamine release. CONCLUSION: The data suggest that unlike most inflammatory cells, PDE-selective inhibitors are ineffective stabilisers of HSMC activity which is similar to HLMC.


Subject(s)
Histamine/metabolism , Lung/pathology , Mast Cells/drug effects , Phosphodiesterase 4 Inhibitors/pharmacology , Phosphoric Diester Hydrolases/metabolism , Skin/pathology , Cell Degranulation , Cells, Cultured , Humans , Immunoglobulin E/metabolism , Mast Cells/immunology , Organic Chemicals/pharmacology , Rolipram/pharmacology , Theophylline/pharmacology , Xanthines/pharmacology
11.
Int J Immunopathol Pharmacol ; 27(4): 473-84, 2014.
Article in English | MEDLINE | ID: mdl-25572726

ABSTRACT

Phosphatases are important enzymes in a variety of biochemical pathways in different cells which they catalyze opposing reactions of phosphorylation and dephosphorylation, which may modulate the function of crucial signaling proteins in different cells. This is an important mechanism in the regulation of intracellular signal transduction pathways in many cells. Phosphatases play a key role in regulating signal transduction. It is known that phosphatases are specific for cleavage of either serine-threonine or tyrosine phosphate groups. To date, numerous compounds have been identified. This paper reviews the classification, roles and pharmacological of protein serine/threonine phosphates.


Subject(s)
Phosphoprotein Phosphatases/physiology , Animals , Humans , Phosphoprotein Phosphatases/antagonists & inhibitors , Phosphoprotein Phosphatases/classification , Phosphorylation , Signal Transduction/physiology
12.
J Am Podiatr Med Assoc ; 82(10): 525-8, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1474485

ABSTRACT

The anatomy, mechanism, and two treatment approaches of an avulsion fracture at the plantar lateral base of the first metatarsal without any joint dislocation were discussed. The authors presented an injury that has not been reported in the literature but has only been seen as a part of Lisfranc's fracture dislocation types B and C.


Subject(s)
Fractures, Closed/etiology , Metatarsal Bones/injuries , Adult , Female , Fractures, Closed/diagnostic imaging , Fractures, Closed/surgery , Humans , Male , Metatarsal Bones/diagnostic imaging , Metatarsal Bones/surgery , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...